If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSP Group Regulatory News (SSPG)

Share Price Information for SSP Group (SSPG)

Share Price is delayed by 15 minutes
Get Live Data
192.70    -0.40 (-0.21%)
Bid:
192.50
Ask:
192.90
Spread: 0.40 (0.208%)
Market Cap: £1.48b
SSPG Live PriceLast checked at - London Stock Exchange

Intraday SSP Group Share Chart

Stabilisation Notice

10 Jul 2014 07:00

RNS Number : 9203L
SSP Group PLC
10 July 2014
 



Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

SSP Group plc ("SSP" or the "Company")

Stabilisation Notice

10 July 2014

Goldman Sachs International (contact: John Bentinck; telephone: +44 (0)20 7774 1000) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

The securities:

Issuer:

SSP Group plc

Securities:

Ordinary shares of the Issuer (ISIN No. GB00BNGWY422)

Offering size:

263,738,787 Shares

Offer price:

GBP 2.10 per Share

Stabilisation:

Stabilising Manager:

Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB

Stabilisation period expected to start on:

10 July 2014

Stabilisation period expected to end no later than:

8 August 2014

Maximum size of over-allotment facility:

Up to 34,400,712 Shares

Over-allotment Option:

Terms:

The Issuer has granted Goldman Sachs International, in its capacity as stabilisation manager and for the account of the underwriters, the option to acquire up to an additional 34,400,712 Shares at the offer price.

Duration:

This option may be executed at any time during the stabilisation period.

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STASSWEEUFLSELW
Date   Source Headline
1st Apr 20256:00 pmRNSHolding(s) in Company
1st Apr 20256:00 pmRNSHolding(s) in Company
31st Mar 20256:20 pmRNSHolding(s) in Company
7th Mar 202511:07 amRNSDirector/PDMR Shareholding
6th Mar 20254:23 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTotal Voting Rights
17th Feb 202510:00 amRNSHolding(s) in Company
6th Feb 20254:39 pmRNSDirector/PDMR Shareholding
30th Jan 20255:00 pmRNSDirector/PDMR Shareholding
30th Jan 20251:13 pmRNSTR1 Notification of major interest in shares
28th Jan 202512:08 pmRNSResult of AGM
28th Jan 20257:00 amRNSQ1 Trading Update
23rd Jan 20257:00 amRNSDirectorate Change
20th Jan 20256:25 pmRNSDirector/PDMR Shareholding
14th Jan 20255:56 pmRNSHolding(s) in Company
13th Jan 20254:07 pmRNSTR1 Notification of major interest in shares
10th Jan 20254:50 pmRNSTR1 Notification of major interest in shares
7th Jan 202510:40 amRNSDirector/PDMR Shareholding
6th Jan 202512:07 pmRNSTR1 Notification of major interest in shares
2nd Jan 202511:43 amRNSTotal Voting Rights
30th Dec 20245:31 pmRNSDirector/PDMR Shareholding
18th Dec 20245:01 pmRNSPublication of Annual Report and Accounts
16th Dec 20244:29 pmRNSDirector/PDMR Shareholding
12th Dec 20243:23 pmRNSDirector/PDMR Shareholding
10th Dec 20245:31 pmRNSPlanned IPO in India of Travel Food Services
6th Dec 20244:06 pmRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSBlock Listing of Ordinary Shares
4th Dec 20241:00 pmRNSTR1 Notification of major interest in shares
3rd Dec 20247:05 amRNSDirectorate Change
3rd Dec 20247:00 amRNS2024 FULL YEAR RESULTS ANNOUNCEMENT
2nd Dec 20241:07 pmRNSBlock listing Interim Review
22nd Nov 202412:48 pmRNSHolding(s) in Company
12th Nov 202412:06 pmRNSBoard Change
11th Nov 20242:15 pmRNSDirector Declaration
7th Nov 202411:21 amRNSDirector/PDMR Shareholding
22nd Oct 20244:09 pmRNSDirector/PDMR Shareholding
14th Oct 202412:45 pmRNSTR1 Notification of major interest in shares
7th Oct 20243:08 pmRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSPre-Close Trading Update
2nd Oct 20246:23 pmRNSDirector/PDMR Shareholding
30th Sep 202410:44 amRNSDirector Declaration
9th Sep 20246:01 pmRNSTR1 Notification of major interest in shares
9th Sep 20246:00 pmRNSDirector/PDMR Shareholding
6th Aug 20242:53 pmRNSDirector/PDMR Shareholding
25th Jul 202410:08 amRNSDirector/PDMR Shareholding
10th Jul 20247:00 amRNSThird Quarter Trading Update
8th Jul 20243:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:00 pmRNSHolding(s) in Company
2nd Jul 20246:18 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.